Royan H9
RIe009-A
General
Cell Line |
|
hPSCreg name | RIe009-A |
Cite as: | RIe009-A (RRID:CVCL_9390) |
Alternative name(s) |
Royan H9
|
Cell line type | Human embryonic stem cell (hESC) |
Similar lines | No similar lines found. |
Last update | 1st September 2022 |
User feedback | |
Provider |
|
Generator |
Royan Institute (RI)
Contact:
Embryonic Stem Cell Biology |
Derivation country | Iran |
External Databases |
|
Cellosaurus | CVCL_9390 |
Wikidata | Q54951010 |
General Information |
|
Publications | |
* Is the cell line readily obtainable for third parties? |
Yes |
Donor Information
General Donor Information |
|
Sex | female |
Phenotype and Disease related information (Donor) |
|
Diseases |
Ethics
Alternatives to consent are available? | Yes |
Alternatives to consent | |
Alternative consent approval number | |
How may genetic information associated with the cell line be accessed? | |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
Name of accrediting authority involved? | National |
Approval number | |
Is there an MTA available for the cell line? | Yes |
hESC Derivation
Supernumerary embryos from IVF treatment? |
Yes
|
PGD Embryo? |
Yes |
Culture Conditions
Feeder cells |
mouse embryonic fibroblast cell Cellfinder Ont Id: EFO_0004040 |
|||||||||||||||||||||
CO2 Concentration | 5 % | |||||||||||||||||||||
Medium |
Other medium:
Base medium: Knockout-DMEM
Main protein source: Fetal bovine serum Serum concentration: 20 % Supplements
|
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
POU5F1 (OCT-4) |
Yes |
|
|
|||
SSEA-3 |
Yes |
|
||||
TRA 1-60 |
Yes |
|
||||
TRA 1-81 |
Yes |
|
||||
NANOG |
Yes |
|
||||
SOX2 |
Yes |
|
Differentiation Potency
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
45, XX, der(13;14)(q10;q10)
|
Other Genotyping (Cell Line) |
Login to share your feedback, experiences or results with the research community.